{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:57:23Z","timestamp":1792713443684,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":6924,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1136\/ijgc-00009577-200601000-00030","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T14:44:58Z","timestamp":1717080298000},"page":"183-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Prophylactic salpingo-oophorectomy in 51 women with familial breast\u2013ovarian cancer: importance of fallopian tube dysplasia"],"prefix":"10.1016","volume":"16","author":[{"given":"K.","family":"Leunen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Legius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Moerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Amant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Vergote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0005","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMed020044","article-title":"Prophylactic oophorectomy to reduce the risk of ovarian and breast cancer in carriers of BRCA mutations","volume":"346","author":"Haber","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0010","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/jnci\/95.13.941","article-title":"Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation","volume":"95","author":"Klaren","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0015","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0020","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1086\/302583","article-title":"The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer susceptibility genes","volume":"65","author":"Gayther","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0025","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/318181","article-title":"Variation in cancer risks, by mutation position, in BRCA2 mutation carriers","volume":"68","author":"Thompson","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0030","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Rish","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0035","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0040","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/sj.bjc.6601656","article-title":"BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast\/ovarian cancer families","volume":"90","author":"Claes","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0045","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.2270482","article-title":"Linkage of early-onset breast cancer to chromosome 17q21","volume":"250","author":"Hall","year":"1990","journal-title":"Science"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0050","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","article-title":"Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13","volume":"265","author":"Wooster","year":"1994","journal-title":"Science"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0055","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1200\/JCO.2003.01.088","article-title":"Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1\/BRCA2 mutation testing","volume":"21","author":"Schwartz","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0060","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0065","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0959-8049(02)00269-1","article-title":"Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers","volume":"38S","author":"Rebbeck","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0070","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0075","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/95.14.1072","article-title":"Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study","volume":"95","author":"Rutter","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0080","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/ijgc-00009577-200201000-00014","article-title":"Use of CA 125 and ultrasound in high-risk women","volume":"12","author":"Laframboise","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0085","series-title":"Familial breast and ovarian cancer: genetics, screening and management","first-page":"6","article-title":"Overview of the clinical benefits of breast cancer","author":"Haites","year":"2002"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1006\/gyno.2000.5740","article-title":"Germline BRCA2 mutation in a patient with fallopian tube carcinoma: a case report","volume":"77","author":"Rose","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0095","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/gyno.2000.6095","article-title":"A genetic epidemiological study of carcinoma of the fallopian tube","volume":"80","author":"Aziz","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00000478-200202000-00003","article-title":"Unexpected gyneco-logic neoplasms in patient with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology and clinical follow-up care","volume":"26","author":"Agoff","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0105","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1200\/JCO.2003.04.131","article-title":"Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations","volume":"21","author":"Levine","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0110","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","article-title":"Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program","volume":"94","author":"Brose","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.2000.6071","article-title":"Occult cancer of the fallopian tube in BRCA1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis","volume":"80","author":"Paley","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0120","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0125","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO;2-J","article-title":"Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer: a report of the Gilda Radner Familial Ovarian Cancer Registry","volume":"71","author":"Piver","year":"1993","journal-title":"Cancer"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/gyno.1998.5267","article-title":"Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factors","volume":"72","author":"Alvarado-Cabrero","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0135","first-page":"28","article-title":"BRCA1 germline mutations in women with uterine serous papillary carcinoma","volume":"96","author":"Lavie","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0140","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/gyno.2000.6082","article-title":"Risk of endometrial carcinoma associated with BRCA mutation","volume":"80","author":"Levine","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0145","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ygyno.2003.11.009","article-title":"BRCA germline mutations in Jewish women with uterine serous papillary carcinoma","volume":"92","author":"Lavie","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0150","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in pro-phylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0155","series-title":"Principles and practice of gynaecologic oncology","first-page":"1104","article-title":"Carcinoma of the fallopian tube","author":"Markman","year":"2000"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0160","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/aje\/kwh103","article-title":"Aggregation of ovarian cancer with breast, ovarian colorectal and prostate cancer in first-degree relatives","volume":"159","author":"Tung","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0165","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/gyno.2002.6638","article-title":"Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy","volume":"85","author":"Colgan","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0170","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1111\/j.1524-4741.2004.101S3.x","article-title":"Efficacy of risk-reducing salpingo-oophorectomy in women with BRCA-1 and BRCA-2 mutations","volume":"10","author":"Olopade","year":"2004","journal-title":"Breast J"},{"issue":"Suppl. 24","key":"10.1136\/ijgc-00009577-200601000-00030_bib0175","first-page":"317","article-title":"Psychological consequences of surgical menopause","volume":"46","author":"Taylor","year":"2001","journal-title":"J Reprod Med"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0090-8258(03)00254-3","article-title":"Ovarian cancer and high-risk women\u2014implications for prevention, screening, and early detection","volume":"91","author":"Modugno","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0185","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1297-9589(03)00058-4","article-title":"Problems raised by the gynaecologic management of women with BRCA1 & 2 mutations","volume":"31","author":"Cabaret","year":"2003","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0190","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/jnci\/91.17.1475","article-title":"Breast cancer risk after bilateral prophylactic oophorectomy in BRCA 1 mutation carriers 1999","volume":"91","author":"Rebbeck","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0195","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0200","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ygyno.2004.02.013","article-title":"Systematic review of management options for woman with a hereditary predisposition to ovarian cancer","volume":"93","author":"Rosen","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200601000-00030_bib0205","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.pgp.0000101082.35393.84","article-title":"Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers","volume":"23","author":"Carcangiu","year":"2004","journal-title":"Int J Gynecol Pathol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24151390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24151390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-00009577-200601000-00030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:17:03Z","timestamp":1753233423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24151390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":41,"aliases":["10.1111\/j.1525-1438.2006.00287.x"],"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S1048891X24151390"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-00009577-200601000-00030","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic salpingo-oophorectomy in 51 women with familial breast\u2013ovarian cancer: importance of fallopian tube dysplasia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-00009577-200601000-00030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2006 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}